ZOLEDRONATE Side Effects

6836987-7 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Female patient from GERMANY , 72 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: .

6836985-3 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
Patient was taking Zoledronate (View Usage). Patient had the following side effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw on Jun 29, 2010 from GERMANY Additional patient health information: Female patient , 67 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Zoledronate dosage: . During the same period patient was treated with PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ).

6836983-X | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
Adverse event was reported on Jun 29, 2010 by a Male patient taking Zoledronate (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: GERMANY , 72 years of age, After Zoledronate was administered, patient had the following side effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw.

6836979-8 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Male patient from GERMANY , 73 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: .


6836977-4 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Female patient from GERMANY , 77 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Zoledronate (View Usage). Patient had the following side effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: .

6836975-0 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw, Stem Cell Transplant
Patient was taking Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw, stem cell transplant on Jun 29, 2010 from GERMANY Additional patient health information: Male patient , 42 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Zoledronate dosage: . During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6836974-9 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
Adverse event was reported on Jun 29, 2010 by a Male patient taking Zoledronate (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: GERMANY , 67 years of age, Patient experienced the following unwanted or unexpected effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6836931-2 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Female patient from GERMANY , 48 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Zoledronate (View Usage). Patient had the following side effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: . During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6836928-2 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Female patient from GERMANY , 80 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: . During the same period patient was treated with IBANDRONATE SODIUM (View Ibandronate Sodium Review and Ibandronate Sodium Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6836924-5 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
Patient was taking Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw on Jun 29, 2010 from GERMANY Additional patient health information: Male patient , 74 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Zoledronate dosage: . During the same period patient was treated with IBANDRONATE SODIUM (View Ibandronate Sodium Review and Ibandronate Sodium Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6836923-3 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw, Stem Cell Transplant
Adverse event was reported on Jun 29, 2010 by a Male patient taking Zoledronate (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: GERMANY , 66 years of age, Patient had the following side effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw, stem cell transplant. During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6835510-0 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Male patient from GERMANY , 69 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: . During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6835499-4 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Female patient from GERMANY , 65 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: . During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6835498-2 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw, Stem Cell Transplant
Patient was taking Zoledronate (View Usage). Patient had the following side effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw, stem cell transplant on Jun 29, 2010 from GERMANY Additional patient health information: Male patient , 70 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Zoledronate dosage: . During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6835493-3 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
Adverse event was reported on Jun 29, 2010 by a Male patient taking Zoledronate (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: GERMANY , 70 years of age, After Zoledronate was administered, patient had the following side effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw.

6835486-6 | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Female patient from GERMANY , 64 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: . During the same period patient was treated with PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6835485-4 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw, Stem Cell Transplant
on Jun 29, 2010 Female patient from GERMANY , 58 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Zoledronate (View Usage). Patient had the following side effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw, stem cell transplant. Zoledronate dosage: . During the same period patient was treated with PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6835483-0 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
Patient was taking Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw on Jun 29, 2010 from GERMANY Additional patient health information: Male patient , 76 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Zoledronate dosage: .

6835482-9 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
Adverse event was reported on Jun 29, 2010 by a Female patient taking Zoledronate (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: GERMANY , 77 years of age, Patient experienced the following unwanted or unexpected effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6835481-7 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Female patient from GERMANY , 58 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Zoledronate (View Usage). Patient had the following side effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: . During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6835475-1 | Actinomycosis, Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw
on Jun 29, 2010 Male patient from GERMANY , 71 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: actinomycosis, bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw. Zoledronate dosage: . During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6835474-X | Bone Disorder, Bone Lesion Excision, Impaired Healing, Osteonecrosis Of Jaw, Stem Cell Transplant
Patient was taking Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, bone lesion excision, impaired healing, osteonecrosis of jaw, stem cell transplant on Jun 29, 2010 from GERMANY Additional patient health information: Male patient , 46 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Zoledronate dosage: . During the same period patient was treated with STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6786375-7 | Hip Fracture
Adverse event was reported on Jun 10, 2010 by a Female patient taking Zoledronate (View Usage) (Dosage: 4 Mg, Qmo) . Location: SINGAPORE , 47 years of age, Patient had the following side effects: hip fracture. During the same period patient was treated with CALCIUM CARBONATE (900 Mg) (View Calcium Carbonate Review and Calcium Carbonate Label ), VITAMIN D (400 Iu) (View Vitamin D Review and Vitamin D Label ).

6756312-X | Femur Fracture, Impaired Healing, Internal Fixation Of Fracture, Pain
on Oct 06, 2009 Male patient from UNITED KINGDOM , 67 years of age, was diagnosed with osteoporosis (What is osteoporosis?) and was treated with Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: femur fracture, impaired healing, internal fixation of fracture, pain (What is pain?). Zoledronate dosage: 1 Infusion, In 3 Month. During the same period patient was treated with ALENDRONATE SODIUM (Unk) (View Alendronate Sodium Review and Alendronate Sodium Label ), IBANDRONATE SODIUM (1 Dose, Monthly) (View Ibandronate Sodium Review and Ibandronate Sodium Label ).

6731833-4 | Osteonecrosis Of Jaw, Sequestrectomy
on May 11, 2010 Male patient from BULGARIA , 66 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis of jaw, sequestrectomy. Zoledronate dosage: . During the same period patient was treated with PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ).

6520224-7 | Abscess Drainage, Abscess Jaw, Debridement, Hypoaesthesia Oral, Jaw Operation, Oral Cavity Fistula, Osteonecrosis, Pain, Swelling
Patient was taking Zoledronate (View Usage). Patient had the following side effects: abscess drainage, abscess jaw, debridement, hypoaesthesia oral, jaw operation, oral cavity fistula, osteonecrosis (What is osteonecrosis?), pain (What is pain?), swelling on Dec 17, 2009 from GERMANY Additional patient health information: Male patient , 72 years of age, was diagnosed with plasmacytoma and. Zoledronate dosage: 4 Mg, Qmo. During the same period patient was treated with PAMIDRONATE DISODIUM (90 Mg, Qmo) (View Pamidronate Disodium Review and Pamidronate Disodium Label ), MELPHALAN (Unk) (View Melphalan Review and Melphalan Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ).

5376822-X | Abscess Jaw, Osteonecrosis, Pain In Jaw
Adverse event was reported on Jun 28, 2007 by a Female patient taking Zoledronate (View Usage) (Dosage: 4 Mg, Qmo) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 53 years of age, After Zoledronate was administered, patient had the following side effects: abscess jaw, osteonecrosis (What is osteonecrosis?), pain in jaw.

5360192-7 | Osteonecrosis, Pain
on Jun 06, 2007 Male patient from BELGIUM , 61 years of age, was diagnosed with metastases to bone and was treated with Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?), pain (What is pain?). Zoledronate dosage: 4mg Every 3-4 Weeks. During the same period patient was treated with CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5360124-1 | Arthralgia, C-reactive Protein Increased, Fall, Muscular Weakness, Musculoskeletal Pain, Polymyalgia Rheumatica, Red Blood Cell Sedimentation Rate Increased
on Jun 05, 2007 Female patient from GERMANY , 82 years of age, weighting 187.4 lb, was diagnosed with osteoporosis (What is osteoporosis?), thrombosis prophylaxis, hypertension, osteoarthritis (What is osteoarthritis?) and was treated with Zoledronate (View Usage). Patient had the following side effects: arthralgia, c-reactive protein increased, fall (What is fall?), muscular weakness, musculoskeletal pain, polymyalgia rheumatica (What is polymyalgia rheumatica?), red blood cell sedimentation rate increased. Zoledronate dosage: 5 Mg, Unk. During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ), ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

5355253-2 | Breast Cancer Metastatic, Fall, Infection, Injury, Osteonecrosis, Pain In Jaw
Patient was taking Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: breast cancer metastatic, fall (What is fall?), infection (What is infection?), injury, osteonecrosis (What is osteonecrosis?), pain in jaw on Jun 07, 2007 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with metastases to bone and. Zoledronate dosage: 4mg, Q 4 Weeks. During the same period patient was treated with LOPRESSOR (Unk, Unk) (View Lopressor Review and Lopressor Label ), DILANTIN (Unk, Unk) (View Dilantin Review and Dilantin Label ), VICODIN (Unk, Unk) (View Vicodin Review and Vicodin Label ), OSCAL (Unk, Unk) (View Oscal Review and Oscal Label ), COMPAZINE (Unk, Unk) (View Compazine Review and Compazine Label ), K DUR 10 (Unk, Unk) (View K-dur 10 Review and K-dur 10 Label ), DIFLUCAN (Unk, Unk) (View Diflucan Review and Diflucan Label ), LASIX (Unk, Unk) (View Lasix Review and Lasix Label ).

5355124-1 | Breast Cancer Metastatic, Fall, Infection, Injury, Osteonecrosis, Pain In Jaw
Adverse event was reported on Jun 07, 2007 by a Female patient taking Zoledronate (View Usage) (Dosage: 4mg, Q 4 Weeks) was diagnosed with metastases to bone and. Location: UNITED STATES , 72 years of age, Patient experienced the following unwanted or unexpected effects: breast cancer metastatic, fall (What is fall?), infection (What is infection?), injury, osteonecrosis (What is osteonecrosis?), pain in jaw. During the same period patient was treated with LOPRESSOR (Unk, Unk) (View Lopressor Review and Lopressor Label ), DILANTIN (Unk, Unk) (View Dilantin Review and Dilantin Label ), VICODIN (Unk, Unk) (View Vicodin Review and Vicodin Label ), OSCAL (Unk, Unk) (View Oscal Review and Oscal Label ), COMPAZINE (Unk, Unk) (View Compazine Review and Compazine Label ), K DUR 10 (Unk, Unk) (View K-dur 10 Review and K-dur 10 Label ), DIFLUCAN (Unk, Unk) (View Diflucan Review and Diflucan Label ), LASIX (Unk, Unk) (View Lasix Review and Lasix Label ).

5353476-X | Mouth Ulceration, Oral Pain, Osteonecrosis
on Jun 06, 2007 Male patient from UNITED STATES , 77 years of age, weighting 178.0 lb, was diagnosed with metastases to bone and was treated with Zoledronate (View Usage). Patient had the following side effects: mouth ulceration, oral pain, osteonecrosis (What is osteonecrosis?). Zoledronate dosage: 4mg, Q 3 Weeks. During the same period patient was treated with BENADRYL (Unk, Unk) (View Benadryl Review and Benadryl Label ), DECADRON #1 (Unk, Unk) (View Decadron #1 Review and Decadron #1 Label ), ZANTAC (Unk, Unk) (View Zantac Review and Zantac Label ), ZOFRAN (Unk, Unk) (View Zofran Review and Zofran Label ), TAXOL (Unk, Unk) (View Taxol Review and Taxol Label ), PROCRIT (Unk, Unk) (View Procrit Review and Procrit Label ), LEUKINE (Unk, Unk) (View Leukine Review and Leukine Label ).

5352012-1 | Osteolysis, Osteonecrosis, Pain In Jaw
on May 31, 2007 Male patient from BELGIUM , 82 years of age, weighting 136.7 lb, was diagnosed with metastases to bone, multiple myeloma (What is multiple myeloma?) and was treated with Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: osteolysis, osteonecrosis (What is osteonecrosis?), pain in jaw. Zoledronate dosage: 4mg Every 4 Weeks. During the same period patient was treated with CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), THALIDOMIDE (150mg Per Day) (View Thalidomide Review and Thalidomide Label ).

5336793-9 | Abscess Jaw, Abscess Rupture, Blood Creatine Increased, Bone Debridement, Erythema, Lymphadenopathy, Osteomyelitis, Osteonecrosis, Renal Failure
Patient was taking Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: abscess jaw, abscess rupture, blood creatine increased, bone debridement, erythema, lymphadenopathy, osteomyelitis, osteonecrosis (What is osteonecrosis?), renal failure on May 17, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 78 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Zoledronate dosage: 4mg Every 3-4 Weeks. During the same period patient was treated with CLODRONATE DISODIUM (View Clodronate Disodium Review and Clodronate Disodium Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ).

5336790-3 | Abscess Jaw, Abscess Rupture, Blood Creatine Increased, Bone Debridement, Erythema, Lymphadenopathy, Osteomyelitis, Osteonecrosis, Renal Failure
Adverse event was reported on May 17, 2007 by a Male patient taking Zoledronate (View Usage) (Dosage: 4mg Every 3-4 Weeks) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED KINGDOM , 78 years of age, weighting 160.9 lb, Patient had the following side effects: abscess jaw, abscess rupture, blood creatine increased, bone debridement, erythema, lymphadenopathy, osteomyelitis, osteonecrosis (What is osteonecrosis?), renal failure. During the same period patient was treated with CLODRONATE DISODIUM (View Clodronate Disodium Review and Clodronate Disodium Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ).

5334269-6 | Blood Alkaline Phosphatase Increased, Blood Calcium Decreased, Blood Parathyroid Hormone Increased, Blood Phosphorus Decreased, Osteocalcin Increased, Vitamin D Decreased
on May 14, 2007 Female patient from UNITED STATES , 93 years of age, was treated with Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: blood alkaline phosphatase increased, blood calcium decreased, blood parathyroid hormone increased, blood phosphorus decreased, osteocalcin increased, vitamin d decreased. Zoledronate dosage: 2 Mg, Once/single. During the same period patient was treated with DIGOXIN (0.125 Unk, Qd) (View Digoxin Review and Digoxin Label ), ENALAPRIL (2.5 Mg, Bid) (View Enalapril Review and Enalapril Label ), TOPROL XL (25 Mg, Qd) (View Toprol-xl Review and Toprol-xl Label ), LASIX (20 Mg, Qd) (View Lasix Review and Lasix Label ), ZOCOR (40 Mg, Unk) (View Zocor Review and Zocor Label ), EFFEXOR (25 Mg, Unk) (View Effexor Review and Effexor Label ), COD LIVER OIL (View Cod-liver Oil Review and Cod-liver Oil Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5331844-X | Blood Alkaline Phosphatase Increased, Blood Calcium Decreased, Blood Parathyroid Hormone Increased, Blood Phosphorus Decreased, Osteocalcin Increased, Vitamin D Decreased
on May 10, 2007 Female patient from UNITED STATES , 93 years of age, was treated with Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, blood calcium decreased, blood parathyroid hormone increased, blood phosphorus decreased, osteocalcin increased, vitamin d decreased. Zoledronate dosage: . Patient was hospitalized.

5329863-2 | Gastrointestinal Pain, Nausea, Osteonecrosis, Surgery
Patient was taking Zoledronate (View Usage). Patient had the following side effects: gastrointestinal pain, nausea (What is nausea?), osteonecrosis (What is osteonecrosis?), surgery (What is surgery?) on May 10, 2007 from GERMANY Additional patient health information: Female patient , 71 years of age, was diagnosed with metastases to bone, breast cancer (What is breast cancer?) and. Zoledronate dosage: 4 Mg, Once A Month. During the same period patient was treated with KEVATRIL (View Kevatril Review and Kevatril Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), TAVEGIL (View Tavegil Review and Tavegil Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), CALCIUM CHLORIDE (500 Mg, Qd) (View Calcium Chloride Review and Calcium Chloride Label ), VITAMIN D (400-500 Iu) (View Vitamin D Review and Vitamin D Label ).

5328312-8 | Osteonecrosis
Adverse event was reported on May 07, 2007 by a Male patient taking Zoledronate (View Usage) (Dosage: 4mg Every 4 Weeks) was diagnosed with metastases to bone, hypertension, gastrooesophageal reflux disease and. Location: NEW ZEALAND , 64 years of age, weighting 218.3 lb, After Zoledronate was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?). During the same period patient was treated with CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACCUPRIL (View Accupril Review and Accupril Label ).

5327037-2 | Bone Disorder, Tooth Extraction
on May 03, 2007 Male patient from UNITED STATES , 64 years of age, weighting 287.5 lb, was diagnosed with metastases to bone and was treated with Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, tooth extraction. Zoledronate dosage: 4 Mg Monthly. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), GOSERELIN ACETATE (View Goserelin Acetate Review and Goserelin Acetate Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ).

5326567-7 | Bone Disorder, Tooth Extraction
on May 03, 2007 Male patient from UNITED STATES , 64 years of age, weighting 287.5 lb, was diagnosed with metastases to bone and was treated with Zoledronate (View Usage). Patient had the following side effects: bone disorder, tooth extraction. Zoledronate dosage: 4 Mg Monthly. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), GOSERELIN ACETATE (View Goserelin Acetate Review and Goserelin Acetate Label ), DARBEPOETIN ALFA (View Darbepoetin Alfa Review and Darbepoetin Alfa Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ).

5323502-2 | Jaw Disorder, Osteonecrosis, Swelling
Patient was taking Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: jaw disorder, osteonecrosis (What is osteonecrosis?), swelling on May 02, 2007 from ITALY Additional patient health information: Female patient , 48 years of age, weighting 105.8 lb, was diagnosed with metastases to bone and. Zoledronate dosage: 4mg Every 3 Months. During the same period patient was treated with VITAMIN D (View Vitamin D Review and Vitamin D Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ).

5323431-4 | Hip Fracture, Osteosynthesis
Adverse event was reported on May 02, 2007 by a Female patient taking Zoledronate (View Usage) (Dosage: 5 Mg) was diagnosed with osteitis deformans and. Location: BELGIUM , 65 years of age, weighting 154.8 lb, Patient experienced the following unwanted or unexpected effects: hip fracture, osteosynthesis. During the same period patient was treated with DIURETICS (View Diuretics Review and Diuretics Label ). Patient was hospitalized.

5317618-4 | Bone Disorder, Osteonecrosis
on Apr 24, 2007 Male patient from UNITED KINGDOM , 66 years of age, weighting 196.2 lb, was diagnosed with metastases to bone and was treated with Zoledronate (View Usage). Patient had the following side effects: bone disorder, osteonecrosis (What is osteonecrosis?). Zoledronate dosage: 4mg Every 3 Weeks. During the same period patient was treated with DOCETAXEL (125mg Q3 W) (View Docetaxel Review and Docetaxel Label ), PREDNISOLONE (10 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), STRONTIUM (150mbq Qmo) (View Strontium Review and Strontium Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5305855-4 | Bone Debridement, Bone Disorder, Local Anaesthesia, Osteitis, Osteonecrosis, Pain, Surgery, Ulcer
on Apr 13, 2007 Female patient from ITALY , 59 years of age, was diagnosed with metastases to bone and was treated with Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: bone debridement, bone disorder, local anaesthesia, osteitis, osteonecrosis (What is osteonecrosis?), pain (What is pain?), surgery (What is surgery?), ulcer (What is ulcer?). Zoledronate dosage: 4 Mg, Qmo. During the same period patient was treated with EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), VINORELBINE (View Vinorelbine Review and Vinorelbine Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5305854-2 | Bone Debridement, Bone Disorder, Local Anaesthesia, Osteitis, Osteonecrosis, Pain, Surgery, Tooth Extraction, Ulcer
Patient was taking Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: bone debridement, bone disorder, local anaesthesia, osteitis, osteonecrosis (What is osteonecrosis?), pain (What is pain?), surgery (What is surgery?), tooth extraction, ulcer (What is ulcer?) on Apr 13, 2007 from ITALY Additional patient health information: Female patient , 64 years of age, was diagnosed with metastases to bone and. Zoledronate dosage: 4 Mg, Qmo. During the same period patient was treated with GEMCITABINE HCL (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ), VINORELBINE (View Vinorelbine Review and Vinorelbine Label ), PAMIDRONATE DISODIUM (90 Mg, Qmo) (View Pamidronate Disodium Review and Pamidronate Disodium Label ).

5305343-5 | Bone Debridement, Bone Disorder, Local Anaesthesia, Osteitis, Osteonecrosis, Pain, Surgery, Tooth Extraction, Ulcer
Adverse event was reported on Apr 13, 2007 by a Female patient taking Zoledronate (View Usage) (Dosage: 4 Mg, Qmo) was diagnosed with metastases to bone and. Location: ITALY , 64 years of age, Patient had the following side effects: bone debridement, bone disorder, local anaesthesia, osteitis, osteonecrosis (What is osteonecrosis?), pain (What is pain?), surgery (What is surgery?), tooth extraction, ulcer (What is ulcer?). During the same period patient was treated with GEMCITABINE HCL (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ), VINORELBINE (View Vinorelbine Review and Vinorelbine Label ), PAMIDRONATE DISODIUM (90 Mg, Qmo) (View Pamidronate Disodium Review and Pamidronate Disodium Label ).

5305320-4 | Bone Debridement, Bone Disorder, Local Anaesthesia, Osteitis, Osteonecrosis, Pain, Paraesthesia Oral, Surgery, Ulcer
on Apr 13, 2007 Female patient from ITALY , 71 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Zoledronate (View Usage). After Zoledronate was administered, patient had the following side effects: bone debridement, bone disorder, local anaesthesia, osteitis, osteonecrosis (What is osteonecrosis?), pain (What is pain?), paraesthesia oral, surgery (What is surgery?), ulcer (What is ulcer?). Zoledronate dosage: 4 Mg, Qmo.

5305311-3 | Bone Debridement, Bone Disorder, Local Anaesthesia, Osteitis, Osteonecrosis, Pain, Surgery, Ulcer
on Apr 13, 2007 Female patient from ITALY , 59 years of age, was diagnosed with metastases to bone and was treated with Zoledronate (View Usage). Patient experienced the following unwanted or unexpected effects: bone debridement, bone disorder, local anaesthesia, osteitis, osteonecrosis (What is osteonecrosis?), pain (What is pain?), surgery (What is surgery?), ulcer (What is ulcer?). Zoledronate dosage: 4 Mg, Qmo. During the same period patient was treated with EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), VINORELBINE (View Vinorelbine Review and Vinorelbine Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

5290528-7 | Osteonecrosis, Tooth Extraction
Patient was taking Zoledronate (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?), tooth extraction on Mar 27, 2007 from IRELAND Additional patient health information: Female patient , 70 years of age, weighting 138.0 lb, was diagnosed with metastases to bone, breast cancer (What is breast cancer?) and. Zoledronate dosage: 4 Mg, Unk. During the same period patient was treated with CALCIUM (View Calcium Review and Calcium Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).